Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatin [1]

M. Gutierrez, P. Pautier, C. Lhommé

    Research output: Contribution to journalLetterpeer-review

    15 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)353
    Number of pages1
    JournalJournal of Clinical Oncology
    Volume20
    Issue number1
    Publication statusPublished - 1 Jan 2002

    Cite this